Imprimer

Votre recherche pour: Allylphosphonate+de+di\u00E9thyle


13 208  les résultats ont été trouvés

Affiner les résultats Trier par

Sort Results

Vue liste Vue simple
SearchResultCount:"13208"

Évaluez le résultat de cette recherche

Image non disponible-BOSSBS-10429R-CY7

Anti-APP Rabbit Polyclonal Antibody (Cy7®)

Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Numéro de catalogue: BOSSBS-10429R-CY7
UOM: 1 * 100 µl
Fournisseur: Bioss
Image non disponible-BOSSBS-0107R-CY7

Anti-APP Rabbit Polyclonal Antibody (Cy7®)

Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Numéro de catalogue: BOSSBS-0107R-CY7
UOM: 1 * 100 µl
Fournisseur: Bioss
Image non disponible-BOSSBS-10429R

Anti-APP Rabbit Polyclonal Antibody

Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Numéro de catalogue: BOSSBS-10429R
UOM: 1 * 100 µl
Fournisseur: Bioss
Image non disponible-BOSSBS-3619R-CY5

Anti-TLN1 + TLN2 Rabbit Polyclonal Antibody (Cy5®)

Description: Talin, a multifunctional constituent of cell-substratum attachment sites, is a high molecular weight protein (225-270 kDa) found in variety of tissues and cell types. It is localized at a subset of adherens junctions, specialized cell-cell and cell-matrix associations that are characterized by the presence of filamentous actin at the cytoplasmic face of the junctional complex. In cultured cells, talin is absent from cell-cell junctions and found predominantly at adhesion plaques and in fibrillar streaks underlying cell surface fibronectin. Talin interacts with at least two other proteins that are localized at adhesion plaques, vinculin and integrin. Talin and vinculin have been shown to interact with each other and both have been proposed to be involved in generating the transmembrane connection, between the extracellular matrix and the cytoskeleton, that occurs at adhesion plaques. At physiological ionic strength, talin is an elongate, flexible, monomeric protein with the ability to self-associate into dimers at higher protein concentrations.
Numéro de catalogue: BOSSBS-3619R-CY5
UOM: 1 * 100 µl
Fournisseur: Bioss
Image non disponible-CAYM38410-500

9(S)-HODE ≥98%

Description: 9(S)-HODE is produced by the lipoxygenation of linoleic acid in both plants and animals. It has been detected in atherosclerotic plaques, as an esterified component of membrane phospholipids and in oxidised LDL particles.
Numéro de catalogue: CAYM38410-500
UOM: 1 * 500 µG
Fournisseur: Cayman Chemical
Image non disponible-BOSSBS-6815R-A350

Anti-LRRC15 Rabbit Polyclonal Antibody (Alexa Fluor® 350)

Description: LRRC15 may contribute to regulation of cell-matrix adhesion interactions with respect to astrocyte recruitment around senile plaques in Alzheimer's disease brain. LRRC15 is induced by EWS-WT1(+KTS) in the tumor DSRCT and may play a role in cellular invasion.
Numéro de catalogue: BOSSBS-6815R-A350
UOM: 1 * 100 µl
Fournisseur: Bioss
Image non disponible-BOSSBS-6815R-FITC

Anti-LRRC15 Rabbit Polyclonal Antibody (FITC (Fluorescein Isothiocyanate))

Description: LRRC15 may contribute to regulation of cell-matrix adhesion interactions with respect to astrocyte recruitment around senile plaques in Alzheimer's disease brain. LRRC15 is induced by EWS-WT1(+KTS) in the tumor DSRCT and may play a role in cellular invasion.
Numéro de catalogue: BOSSBS-6815R-FITC
UOM: 1 * 100 µl
Fournisseur: Bioss
Image non disponible-BOSSBS-0107R-CY5.5

Anti-APP Rabbit Polyclonal Antibody (Cy5.5®)

Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Numéro de catalogue: BOSSBS-0107R-CY5.5
UOM: 1 * 100 µl
Fournisseur: Bioss
Image non disponible-BOSSBS-10429R-CY5

Anti-APP Rabbit Polyclonal Antibody (Cy5®)

Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Numéro de catalogue: BOSSBS-10429R-CY5
UOM: 1 * 100 µl
Fournisseur: Bioss
Image non disponible-BOSSBS-10429R-A555

Anti-APP Rabbit Polyclonal Antibody (Alexa Fluor® 555)

Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Numéro de catalogue: BOSSBS-10429R-A555
UOM: 1 * 100 µl
Fournisseur: Bioss
Image non disponible-BOSSBS-0076R-CY7

Anti-APP Rabbit Polyclonal Antibody (Cy7®)

Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Numéro de catalogue: BOSSBS-0076R-CY7
UOM: 1 * 100 µl
Fournisseur: Bioss
Image non disponible-BOSSBS-0076R-A350

Anti-APP Rabbit Polyclonal Antibody (Alexa Fluor® 350)

Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Numéro de catalogue: BOSSBS-0076R-A350
UOM: 1 * 100 µl
Fournisseur: Bioss
Image du produit-1.15445.0001

Plaques HPTLC avec gels de silice sphérique, LiChrospher®

Description: Les plaques HPTLC LiChrospher® sont basées sur de la silice 60 de forme sphérique avec une taille de particule de 7 µm et une distribution granulométrique étroite similaire aux phases utilisées en HPLC. Les plaques HPTLC LiChrospher® possèdent une sélectivité comparable aux plaques HPTLC respectives, cependant, la hauteur de la plaque et les nombres de séparation sont encore améliorés, ce qui entraîne des temps d'analyse plus courts.
Numéro de catalogue: 1.15445.0001
UOM: 1 * 25 ST
Fournisseur: Merck

MSMD


Image non disponible-BOSSBS-0076R-CY5

Anti-APP Rabbit Polyclonal Antibody (Cy5®)

Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Numéro de catalogue: BOSSBS-0076R-CY5
UOM: 1 * 100 µl
Fournisseur: Bioss
Image non disponible-BOSSBS-0076R-A555

Anti-APP Rabbit Polyclonal Antibody (Alexa Fluor® 555)

Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Numéro de catalogue: BOSSBS-0076R-A555
UOM: 1 * 100 µl
Fournisseur: Bioss
Image non disponible-BOSSBS-0107R-CY3

Anti-APP Rabbit Polyclonal Antibody (Cy3®)

Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Numéro de catalogue: BOSSBS-0107R-CY3
UOM: 1 * 100 µl
Fournisseur: Bioss
97 - 112 of 13 208